Trial could pave way for Japanese OK of Abbott's heart stent

06/17/2013 | (Boston)

Abbott has begun a Japanese clinical study of its Absorb Bioresorbable Vascular Scaffold, a drug-eluting stent that dissolves in the cardiac vessel slowly to eventually bring the vessel back to its normal functioning state. The trial, which will involve about 400 patients with coronary artery disease, will back the company's pursuit for regulatory approval in Japan.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ